Multivariate analyses of prognostic factors’ effect on TTP in all PMBCL patients (N = 159)
| Clinical feature . | HR (95% CI) . | P . |
|---|---|---|
| Pleural and/or pericardial effusion | 2.09 (1.00-4.37) | .05 |
| B symptoms | 1.94 (0.96-3.95) | .06 |
| Stage III/IV disease | 2.30 (1.11-4.75) | .02 |
| Clinical feature . | HR (95% CI) . | P . |
|---|---|---|
| Pleural and/or pericardial effusion | 2.09 (1.00-4.37) | .05 |
| B symptoms | 1.94 (0.96-3.95) | .06 |
| Stage III/IV disease | 2.30 (1.11-4.75) | .02 |
HR, hazard ratio; IPI, International Prognostic Index; ULN, upper limit of normal.